Back to top

Goldman Sachs Remains a Buy on Sotera Health (SHC)

Goldman Sachs analyst Evie Koslosky maintained a Buy rating on Sotera Health yesterday and set a price target of $22.00. The company’s shares close...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Sotera Health Company (SHC)